Connecting clients, partners and patients to develop new treatments for diabetes and related metabolic diseases.

Science Driven Therapeutically Focused

Delivering on the Potential of Innovative Therapeutics for Metabolic Diseases

Advise • Advance • Achieve

Clinical Development and Regulatory Strategy + State-of-the-Art Clinical Facility + Full Scope CRO Services + Global Scientific Network

ProSciento Services

Specialty consulting services for clinical development, regulatory strategy and licensing.
State-of-the-art clinical research facilities for metabolic drug and device clinical trials.
Full scope, comprehensive multi-site services to support metabolic clinical research programs.
Global network of partners connecting our clients to the most innovative research methods.


June 7, 2017

ProSciento and OWL Metabolomics Form Strategic Collaboration Focused on Accelerating NAFLD/NASH Clinical Trial Recruitment Read More »

May 30, 2017

ProSciento Appoints Dr. Kelvin Logan, Former Executive at INC Research and Quintiles, to its Board of Directors Read More »


View Our Presentation


August 3, 2017

Diabetes drug shows potential as disease-modifying therapy for Parkinson’s disease Read More »

July 19, 2017

CDC releases diabetes, prediabetes statistics in US Read More »

July 9, 2017

Aetna publishes diabetes prevalence paper based on insurance claims Read More »